Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Pharmacokinetic Study of Intravenous and Oral Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non-Hodgkin's Lymphoma.

NCT00742495 is registered in ClinicalTrials.gov with Mundipharma Research Limited as lead sponsor.

NCT NCT00742495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00742495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Pharmacokinetic Study of Intravenous and Oral Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non-Hodgkin's Lymphoma.
Lead sponsor
Mundipharma Research Limited
Phase
Phase 1/2
Overall status
Terminated
Start date
March 31, 2009
Completion date
September 30, 2010
Enrollment
2 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell precursor acute lymphoblastic leukaemia, relapsed or refractory t-cell acute lymphoblastic leukaemia, t-cell non-hodgkin's lymphoma